Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06045975
Title Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by Electroporation Ablation (DUMELEP)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Assistance Publique - Hôpitaux de Paris
Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.